Planned acquisition of 39% equity of Heilongjiang Agriculture Reclamation Agricultural Machinery and Equipment by the First Tractor for a total of 19.7925 million yuan in 1979
Tractor Company Limited (00038) announced that the company has successfully won the bid to sell equity, with the final bidding price being 19.7925 million RMB. On May 18, 2026, the company entered into a equity transfer agreement with Intelligent Research Institute Company. According to the agreement, Intelligent Research Institute Company has agreed to sell and the company has agreed to purchase 39% equity of the target company Heilongjiang Beida Kenaing Agricultural Machinery Equipment Co., Ltd. at the final bidding price.
FIRST TRACTOR (00038) announced that the company has successfully won the bid for the sale of equity. The final bid price was 19.7925 million RMB. On May 18, 2026, the company entered into a stock transfer agreement with the Intelligent Research Institute, wherein the Intelligent Research Institute agreed to sell and the company agreed to purchase 39% equity of Heilongjiang Agriculture Reclamation Agricultural Machinery Equipment Co., Ltd. at the final bid price.
This equity investment will help deepen the company's cooperation with Heilongjiang Agriculture Reclamation Group Ltd., and respond to the national policy of "building a leading zone for the R&D, manufacturing, promotion, and application of large-scale, high-horsepower, high-end intelligent agricultural machinery equipment". By leveraging the large-scale application scenarios of high-end intelligent agricultural machinery equipment of Heilongjiang Agriculture Reclamation Group Ltd., the company will continuously optimize core technical performance, accelerate the R&D, manufacturing, promotion, and application of high-end products, and better serve and protect the national food security.
Related Articles

US Stock Market Move | The new L9 Livis model is priced too high, causing Li Auto, Inc. Sponsored ADR Class A (LI.US) to plummet nearly 10% at the opening.

AI risks driving companies to increase investment in network protection! CrowdStrike (CRWD.US) and Zscaler (ZS.US) receive target price upgrades on Wall Street.

US Stock Market Move | The phase III trial of melanoma drug did not reach the primary endpoint, causing Regeneron Pharmaceuticals, Inc. (RENG.US) to drop more than 10% in early trading.
US Stock Market Move | The new L9 Livis model is priced too high, causing Li Auto, Inc. Sponsored ADR Class A (LI.US) to plummet nearly 10% at the opening.

AI risks driving companies to increase investment in network protection! CrowdStrike (CRWD.US) and Zscaler (ZS.US) receive target price upgrades on Wall Street.

US Stock Market Move | The phase III trial of melanoma drug did not reach the primary endpoint, causing Regeneron Pharmaceuticals, Inc. (RENG.US) to drop more than 10% in early trading.






